The combo drug sacubitril/valsartan was associated with early improvements in health status in a study of nearly 4,000 patients with HFrEF.

Most patients on DOACs supplement their regimen with over-the-counter products, and one-third take at least one additional product that directly interferes with their blood thinners, according to work published in the Journal of the American Geriatrics Society.

Metformin use is linked to a lower risk of hospitalization for heart failure in patients with type 2 diabetes, a paper in the Journal of the American Heart Association confirms.

A study of patients undergoing catheter ablation of atrial fibrillation between 2010 and 2015 found that early post-ablation mortality rates increased over the half-decade, reaching 1.35% per quarter by the end of the research period.

Finalized results from the OSLER-1 trial—the longest-running study of PCSK9 inhibitors to date—suggest evolocumab is safe and “consistently excellent” at lowering LDL-cholesterol through five years.

Hackensack University Medical Center is the first practice in the U.S. to successfully perform heart surgeries using Abiomed’s Impella 5.5 LVAD.

Facebook introduced a new tool this week that provides the platform’s users with personalized healthcare recommendations, CNN reports.

Bulimia nervosa places women at a significantly greater risk of CVB and death than women who have not been diagnosed with the condition, a JAMA Psychiatry study reveals.